Aristeia Capital’s Forbion European Acquisition Corp. Class A Ordinary Shares FRBN Stock Holding History

Aristeia Capital’s Portfolio FRBN Stock Details FRBN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-242,818	Closed	-$2.66M	–	273
2023 Q3	$2.66M	Sell	242,818 -92	-0%	-$1K	0.07%	60
2023 Q2	$2.61M	Sell	242,910 -69,600	-22%	-$738K	0.06%	97
2023 Q1	$3.29M	Hold	312,510	–	–	0.08%	176
2022 Q4	$3.23M	Hold	312,510	–	–	0.06%	268
2022 Q3	$3.16M	Hold	312,510	–	–	0.05%	339
2022 Q2	$3.13M	Hold	312,510	–	–	0.06%	329
2022 Q1	$3.12M	Buy	+312,510	New	+$3.1M	0.06%	317

Aristeia Capital's FRBN Position: Q4 2023 in Review

Aristeia Capital sold out of Forbion European Acquisition Corp. Class A Ordinary Shares (FRBN) in Q4 2023, closing a stake of 242,818 shares — an estimated $2.66M sold.

Aristeia Capital first reported a position in FRBN in Q1 2022 and held it in 7 quarters. The position peaked at $3.29M in Q1 2023. 0 funds tracked by Wall St. Rank hold FRBN as of Q4 2023.

Aristeia Capital reported no remaining Forbion European Acquisition Corp. Class A Ordinary Shares position as of Q4 2023 after selling out during the quarter.
Aristeia Capital sold 242,818 Forbion European Acquisition Corp. Class A Ordinary Shares shares in Q4 2023, an estimated $2.66M.
Aristeia Capital first reported a position in Forbion European Acquisition Corp. Class A Ordinary Shares in Q1 2022 and held it in 7 quarters.
Aristeia Capital's Forbion European Acquisition Corp. Class A Ordinary Shares position peaked at $3.29M in Q1 2023.
0 funds tracked by Wall St. Rank held Forbion European Acquisition Corp. Class A Ordinary Shares as of Q4 2023.

Based on Aristeia Capital's 13F filing for Q4 2023, filed 14 Feb 2024.